Short-term Efficacy of Commercial Curcumin Nanomicelle on Cognition, Oxidative Stress and Choline Esterase in Alzheimer’s Disease
Basic and Clinical Neuroscience Journal · 01.05.2025 · 16 (3) · 595-608
DOI: 10.32598/bcn.2024.4970.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic and Clinical Neuroscience Journal, erschienen am 01.05.2025. Verfasst von Samira Kazemi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences Branch, Islamic Azad University, …. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Introduction
Alzheimer's disease (AD) is a progressive neurodegenerative disease accompanied by cognitive dysfunction. Preclinical changes can precede the onset of clinical symptoms by decades, highlighting the need for preventative and therapeutic strategies to mitigate or delay disease progression. This pilot clinical trial aimed to investigate the effects of commercially available curcumin nanomicelles on oxidative stress pathways and serum cholinesterase levels in patients with AD.
Methods
Fifteen volunteers with mild-to-severe AD and 15 age-matched healthy controls were enrolled. Participants with AD received 80 mg of thermodynamically stable 10 nm curcumin nanomicelles on alternate days for two months. Cognitive function, as assessed by the mini-mental state examination (MMSE), did not exhibit significant changes in patients with AD following curcumin nanomicelle administration (19.8 versus 20.6). Serum levels of oxidative stress biomarkers, including catalase (CAT), superoxide dismutase (SOD) inhibition, malondialdehyde (MDA) concentration, and cholinesterase activity, were evaluated before and after intervention.
Results
The results showed no significant differences in cognition improvement, CAT activity, SOD inhibition, MOD concentration, or cholinesterase activity between patients with AD and healthy controls or before and after curcumin nanomicelle administration.
Conclusion
Although curcumin nanocarriers did not enhance antioxidant biomolecule levels, they did not provoke lipid peroxidation. Therefore, this study suggests that optimizing nanocarrier parameters, including concentration, particle size larger than 10 nm, and blood-brain barrier (BBB)targeting, warrants further investigation in a long-term study to explore their potential as supplemental therapies for AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.
- Department of Cognitive Rehabilitation, Brain and Cognition Clinic, Institute for Cognitive Science Studies, Tehran, Iran.
- College of Medicine, Howard University, Washington DC, United States.
- Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Department of Research and Development, Tavakol BioMimetic Technologies Co, Tehran, Iran.
ORCID-Profile: Samira Kazemi, Mohammad Taghi Joghataei, Shima Tavakol, Sepide Arbabi Bidgoli
Zitieren
APA
Kazemi, S., Hesni Langroudi, N., Hasani Abharian, P., Tavakol, K., Joghataei, M. T., Tavakol, S., & Arbabi Bidgoli, S. (2025). Short-term Efficacy of Commercial Curcumin Nanomicelle on Cognition, Oxidative Stress and Choline Esterase in Alzheimer’s Disease. Basic and Clinical Neuroscience Journal, 16(3), 595-608. https://doi.org/10.32598/bcn.2024.4970.1
Vancouver
Kazemi S, Hesni Langroudi N, Hasani Abharian P, Tavakol K, Joghataei MT, Tavakol S, et al. Short-term Efficacy of Commercial Curcumin Nanomicelle on Cognition, Oxidative Stress and Choline Esterase in Alzheimer’s Disease. Basic and Clinical Neuroscience Journal. 2025;16(3):595-608. doi:10.32598/bcn.2024.4970.1
BibTeX
@article{Kazemi2025,
author = {Kazemi, Samira and Hesni Langroudi, Narges and Hasani Abharian, Peyman and Tavakol, Kamran and Joghataei, Mohammad Taghi and Tavakol, Shima and Arbabi Bidgoli, Sepide},
title = {Short-term Efficacy of Commercial Curcumin Nanomicelle on Cognition, Oxidative Stress and Choline Esterase in Alzheimer’s Disease},
journal = {Basic and Clinical Neuroscience Journal},
year = {2025},
volume = {16},
number = {3},
pages = {595--608},
doi = {10.32598/bcn.2024.4970.1}
}
EUVIMED